Followup of glaucoma trials shows laser treatment safe and effective

MAY 13, 2009--IOPtima (Ramat Gan, Israel) says its laser-based therapy for reducing intraocular pressure (IOP) without penetrating the eye membrane has proven safe and effective. The statement references a 12-month followup to human clinical trials in Mexico and India investigating glaucoma treatment. The company's OT134 carbon dioxide laser to ablate the scleral membrane to an optimal thickness that allows percolation of intraocular fluid.

"The long-term maintenance of the IOP reduction, compiled with the high safety profile, as demonstrated in our clinical studies, place IOPtima's system for glaucoma treatment in the first line of accepted glaucoma treatments," said IOPtima CEO Dr. Joshua Degani.

Combined results showed an average reduction in IOP from 25.5 mm Hg to 14.6 mm Hg (43%). Data also showed that the procedure reduced the average number of glaucoma medications from 2.6 to 0.6. The procedure kept IOP below 18 mm Hg regardless of medication use in 95% of patients and under 18 mm Hg with no additional medications in 67% of patients.

IOPtima's goal is to achieve the effect of non-penetrating deep sclerectomy (NPDS) surgery while removing the risk of perforating the membrane and minimizing the risk of perforating the scleral tissue via its CO2 laser-based system which is self-terminating once the desired scleral thickness has been achieved. This elegant self-regulation is possible because the CO2 laser essentially stops ablating as soon as it comes in contact with the intra-ocular percolated liquid, which is what occurs as soon as the laser reaches the optimal residual intact layer thickness.

The company hopes its OT134 will make non-penetrating deep sclerectomy surgery accessible to all eye surgeons in a safe, fast and cost effective manner.
Currently the most efficient currently-used surgical approach is trabeculectomy; NPDS is a similar but modified procedure causing a significantly smaller number of side effects. Both approaches reduce intraocular pressure, the key cause of glaucoma, by removing scleral tissue in a small flap of the eye.

Whereas in conventional trabeculectomy, the surgeon penetrates through the wall of the eye, in the NPDS procedure, the surgeon penetrates only to approximately 95% of the scleral depth while leaving a residual intact thin layer of several dozen microns. Doing so without inadvertently perforating the thin trabecular membrane is at present very demanding, very time consuming and requires great skill and vast experience. Consequently only a small number of eye surgeons are able to perform this procedure, and the potential benefits of the non-penetrating surgical approach are not widely available to glaucoma patients.

IOPtima is a subsidiary of Bio-Light Life Sciences. For more information see the IOPtima page on the Bio-Light website.

Posted by Barbara G. Goode,, for BioOptics World.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

(SLIDESHOW) View the July/August 2013 issue

Sales of Coherent lasers for ophthalmology exceed 10,000 units

Coherent has now shipped over 10,000 lasers into ophthalmic applications, including pulsed excimer ultraviolet lasers for LASIK vision correction and continuous-wave (CW) solid-state lasers with gr...

WaveTec Vision secures $16.5M to market cataract surgery system

WaveTec Vision has closed a new round of financing for its recently introduced ORA System, a wavefront aberrometry system for cataract surgery, securing an additional $16.5 million.

Anterior segment module receives FDA clearance

Heidelberg Engineering has gained FDA clearance for its Spectralis anterior segment module, which provides high-resolution images of the cornea, anterior chamber angle, and sclera using the company...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS